https://www.selleckchem.com/products/go-6983.html
https://www.selleckchem.com/products/go-6983.html
Probable Immunotherapeutic Methods Determined by Carcinogen-Dependent Subgroup Distinction with regard to Oral Most cancers. Posterior reversible encephalopathy syndrome (PRES) is a rare disorder with multiple causes but potentially caused by chemotherapy. We present 3 cases of PRES of whom 2 are presumably caused by oxaliplatin and one by regorafenib. We discuss in this article the 3 cases individually and we summarize in the discussion the proposed theories in the literature of p
Like
Comment
Share
